- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 175.23M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $11.04M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $108.78M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $110.92M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $12.33M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $9.23M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.24M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $14.29M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.99M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $18.66M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $127.97M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $131.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $240.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $263.05M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 178.48M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.82M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$22.7M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $280.41M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $306.27M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.59M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $7.97M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$15.59M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$18.99M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |